Phase I Vaccination Trial in Metastatic Uveal Melanoma Using IKKb-matured Dendritic Cells Loaded With Autologous Tumor-RNA + RNA Coding for Defined Antigens and Driver Mutations
A Phase I vaccination trial in patients suffering from recently diagnosed metastatic uveal melanoma not cureable with local therapy and needing systemic therapy. IKKb-matured Dendritic Cells loaded with autologous tumor-RNA + RNA coding for defined antigens and driver mutations will be added to a standard therapy chosen by the tumor board (either checkpoint blockade or chemotherapy).
100 项与 Hasumi International Research Foundation Bulgaria 相关的临床结果
0 项与 Hasumi International Research Foundation Bulgaria 相关的专利（医药）
100 项与 Hasumi International Research Foundation Bulgaria 相关的药物交易
100 项与 Hasumi International Research Foundation Bulgaria 相关的转化医学
